Entropy Technologies’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.44M Buy
37,619
+19,298
+105% +$4.81M 0.39% 74
2025
Q4
$4.41M Buy
18,321
+1,804
+11% +$461K 0.24% 118
2025
Q3
$4.52M Buy
16,517
+133
+0.8% +$36.3K 0.34% 78
2025
Q2
$4.23M Buy
16,384
+10,708
+189% +$2.55M 0.34% 71
2025
Q1
$1.27M Buy
5,676
+4,587
+421% +$1.07M 0.12% 226
2024
Q4
$249K Sell
1,089
-6,581
-86% -$1.58M 0.03% 581
2024
Q3
$1.87M Buy
+7,670
New +$1.71M 0.2% 154
2024
Q2
Sell
-3,082
Closed -$610K 900
2024
Q1
$610K Sell
3,082
-16,988
-85% -$3.11M 0.07% 393
2023
Q4
$3.45M Buy
+20,070
New +$3.08M 0.64% 13

Other funds holding RMD

Entropy Technologies's RMD Position: Q1 2026 in Review

Entropy Technologies increased its ResMed (RMD) stake by 105% in Q1 2026, buying an estimated $4.81M and bringing the position to 37,619 shares worth $8.44M. The position accounts for 0.39% of the portfolio, ranked #74.

Entropy Technologies first reported a position in RMD in Q4 2023 and has held it in 9 quarters since. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Entropy Technologies held 37,619 shares of ResMed worth $8.44M as of Q1 2026.
  • Entropy Technologies bought 19,298 ResMed shares in Q1 2026, an estimated $4.81M.
  • ResMed made up 0.39% of Entropy Technologies's portfolio in Q1 2026, its #74 holding.
  • Entropy Technologies first reported a position in ResMed in Q4 2023 and has held it in 9 quarters since.
  • 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Entropy Technologies's 13F filing for Q1 2026, filed 14 May 2026.